Parkinson’s Disease

Category

George Washington University Study Asks: Can Nilotinib be Repurposed from use for Specific Cancer to use for Parkinson’s Disease?

There is tremendous value in identifying new purposes for existing drugs. Recently, Georgetown University Medical Center (GUMC) embarked on a project to do just that for Parkinson’s disease with a cancer drug called nilotinib (Tasigna). They found that the drug in...

Parkinson’s UK & King’s College London Plan Pioneering Clinical Trial to Treat Psychosis in Parkinson’s Patients Using Cannabidiol

Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, has partnered with investigators at King’s College London to invest £1.2 million in a pioneering Phase II clinical trial investigating the use of cannabidiol (CBD)—a compound found...

Suncoast Neuroscience Associates Conducting Parkinson’s Clinical Trial in Florida for Parkinson’s Disease Patients Exhibiting Hallucinations and Delusions.

Suncoast Neuroscience Associates, a dedicated clinical investigational site, is actively recruiting participants for a clinical research study to evaluate an investigational medicine in people diagnosed with Parkinson’s disease exhibiting hallucinations and delusions....